Rheumatologic AgentsArava (leflunomide)
Manufacturer: Aventis Pharmaceuticals
Drug Approval Classification: Supplemental New Drug Application (Approval Date: 10/03)
Warnings: The labeling for Arava (leflunomide) has been updated to include postmarketing reports of serious hepatic injury.
Complete monitoring guidelines are included in the revised labeling.
Medscape Pharmacists. 2003;5(1) © 2003 Medscape
Cite this: December 2003 - Medscape - Dec 15, 2003.